Volex Profit Outlook Lift
Volex Shares Jump as FY2027 Profit Forecasts Exceed Current Market Expectations
Key Points
Volex shares jumped about 20% after the trading update, signaling market optimism about FY2027 profitability following the strong start to the year.
There is clearer momentum beyond the headline 28% growth: average monthly revenue in the first four months was around 8% higher than the second half of FY2026, suggesting underlying momentum.
Data Centre demand within Complex Industrial Technology has been sustained at the elevated exit-rate level seen at the end of FY2026, reinforcing the division as the growth driver.
Integration of the remaining stake in Kepler SignalTek is progressing in line with plan, extending Volex’s medical offering into patient-to-device applications.
Volex, a UK manufacturer of power and data transmission products, expects full-year profit for 2027 to beat market forecasts after a blistering start to the financial year. The company reported 28% constant-currency revenue growth in its first four months, driven by demand for electric vehicle components and data centre equipment, prompting shares to jump roughly 20% Investing UK Investor Magazine.
Management signalled confidence in exceeding consensus expectations of around $1.34 billion in revenue and $138 million in operating profit for the full year. The momentum reflects genuine underlying demand beyond favourable comparisons with last year's weaker period Proactive Investors.
Electric Vehicle Demand Drives Growth Across Markets
All five of Volex's end-markets showed gains in the four-month period, with Complex Industrial Technology leading the charge. The division benefited from surging demand for EV components and electrification systems, while data centre equipment orders remained strong at the elevated levels seen at the end of fiscal 2026 UK Investor Magazine. This sustained momentum suggests the growth isn't merely a statistical quirk from easier comparisons.
Cost Control and Operating Leverage Improve Margins
Volex's tight management of costs combined with operating leverage from higher sales volumes strengthened underlying operating margins during the period. The company maintained robust sequential growth month-to-month, suggesting the business can sustain momentum even as the year-on-year growth rate normalises UK Investor Magazine.
Medical Expansion Through Kepler SignalTek Acquisition
Volex completed its acquisition of the remaining stake in Kepler SignalTek, broadening its medical device offerings into patient-to-device applications. The integration is progressing on schedule and positions the company to capture growing demand in healthcare electronics, a sector expected to benefit from ageing populations and increased digitalisation Investing.
Main Market Listing Marks Major Milestone
On 24 July, Volex completed its transition from the AIM market to the London Stock Exchange's Main Market, a significant step in the company's trajectory as a public company. The upgrade typically signals improved governance and access to a broader pool of institutional investors, reinforcing confidence in the company's long-term growth prospects UK Investor Magazine.
Sentiment
Mostly PositivePublishers
12
Articles
25
Reach
37
